Evidence for AMPK-dependent regulation of exocytosis of lipoproteins in a model liver cell line.

Experimental Cell Research
Livia PuljakGordan Kilic

Abstract

5'-AMP-activated kinase (AMPK) plays a key role in the regulation of cellular lipid metabolism. The contribution of vesicular exocytosis to this regulation is not known. Accordingly, we studied the effects of AMPK on exocytosis and intracellular lipid content in a model liver cell line. Activation of AMPK by metformin or 5-aminoimidazole-4-carboxamide-1-beta-d-ribofuranoside (AICAR) increased the rates of constitutive exocytosis by about 2-fold. Stimulation of exocytosis by AMPK occurred within minutes, and persisted after overnight exposure to metformin or AICAR. Activation of AMPK also increased the amount of triacylglycerol (TG) and apolipoprotein B (apoB) secreted from lipid-loaded cells. These effects were accompanied by a decrease in the intracellular lipid content indicating that exocytosis of lipoproteins was involved in these lipid-lowering effects. While AMPK increased the rates of fatty acid oxidation (FAO), the lipid-lowering effects were quantitatively significant even after inhibition of FAO with R-etomoxir. These results suggest that hepatic AMPK stimulates constitutive exocytosis of lipoproteins, which may function in parallel with FAO to regulate intracellular lipid content.

References

May 25, 1978·Biochimica Et Biophysica Acta·G P MannaertsD W Foster
Jul 1, 1977·The Journal of Clinical Investigation·J D McGarryD W Foster
Jan 1, 1990·Annual Review of Nutrition·J E Vance, D E Vance
Feb 1, 1988·Pflügers Archiv : European journal of physiology·M Lindau, E Neher
Apr 15, 1999·Annual Review of Neuroscience·A J CochillaW J Betz
Nov 30, 2000·The Journal of Biological Chemistry·Y LeeR H Unger
Oct 17, 2001·The Journal of Clinical Investigation·G ZhouD E Moller
Jan 18, 2002·Nature·Yasuhiko MinokoshiBarbara B Kahn
Jun 28, 2003·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Philippe LettéronDominique Pessayre
Sep 6, 2003·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Dean GilhamRichard Lehner
Jan 30, 2004·Biochemical Society Transactions·G F GibbonsA-M Hebbachi
Jun 30, 2004·Cellular and Molecular Life Sciences : CMLS·V W DolinskyR Lehner
Jul 1, 2004·Alimentary Pharmacology & Therapeutics·S NairR P Perrillo
Apr 22, 2005·The American Journal of Gastroenterology·Elisabetta BugianesiGiulio Marchesini

❮ Previous
Next ❯

Citations

Feb 18, 2009·The Journal of Clinical Investigation·Zhongsheng PengBruce N Cronstein
Apr 5, 2011·Current Atherosclerosis Reports·S Hani Najafi-Shoushtari
Apr 23, 2011·Expert Opinion on Drug Metabolism & Toxicology·David E Amacher
Nov 10, 2015·Chemistry & Biology·Charlene DepryJin Zhang
Feb 28, 2009·Acta Physiologica·B D HegartyE W Kraegen
Aug 26, 2016·Cell Biochemistry and Function·Yujie LiangJingchen Liu
Oct 8, 2009·American Journal of Physiology. Gastrointestinal and Liver Physiology·Geneviève MailhotEmile Levy
Sep 14, 2012·American Journal of Physiology. Cell Physiology·Feng XiaoGordan Kilic

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.